[Asia Economy Reporter Geum Bo-ryeong] GL PharmTech announced on the 29th that it has decided to conduct a third-party allotment paid-in capital increase to raise approximately 1 billion KRW in operating funds.



The newly issued shares are 1,023,542 common shares, with a par value of 100 KRW per share.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing